Serial Sampling of ST2 Predicts 90-Day Mortality Following Destabilized Heart Failure
- 30 November 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Cardiac Failure
- Vol. 14 (9), 732-738
- https://doi.org/10.1016/j.cardfail.2008.06.415
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemJCI Insight, 2007
- IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated CytokinesImmunity, 2005
- 509 Benefit of BNP for optimising therapy in patients with heart failure due to systolic dysfunction: The Systolic heart failure treatment supported by BNP trial (STARS-BNP) multicenter randomised studyEuropean Journal of Heart Failure Supplements, 2005
- High Intraindividual Variation of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in Patients with Stable Chronic Heart FailureClinical Chemistry, 2004
- N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure PatientsCirculation, 2004
- Serum Levels of the Interleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial InfarctionCirculation, 2004
- Expression and Regulation of ST2, an Interleukin-1 Receptor Family Member, in Cardiomyocytes and Myocardial InfarctionCirculation, 2002
- Anti-inflammatory Cytokine Profile in Human Heart FailureJapanese Circulation Journal, 1999
- Stress activated cytokines and the heartCytokine & Growth Factor Reviews, 1996
- Left ventricular volume from paired biplane two-dimensional echocardiography.Circulation, 1979